About Us
RCMG’s proprietary technology platform is able to continually create novel biomarkers/in vitro diagnostics (IVDs) to detect specific disease conditions suitable for the diversity of personalized medicine.
RCMG’s proprietary technology platform is able to continually create novel biomarkers/in vitro diagnostics (IVDs) to detect specific disease conditions suitable for the diversity of personalized medicine.
In the Glycoscience, new technologies based on engineering in addition to biochemistry and molecular biology promote new findings in medicine.
Hepatitis B virus (HBV), one of the most human infected viruses, has been a global health problem. A recombinant monoclonal antibody against HBsAg glycan isomer (HBsAgGi) was cloned and available from RCMG Inc.
Glyco-S ELISA system can measure HBsAg glycosylation of genotype A, B, C, and D.
2-1-6 Sengen, Plaza Suite 106, Tsukuba, Ibaraki 305-0047
TEL：+81-29-828-8010
marketing@rcmg-glyco.com
Service
Home
About Us
Products & Services
• Research Products
• Contract Services
Projects
News
Access
Contact
Japanese Website
© Copyright 2022 RCMG Inc.
Contact Us
